{"name":"Hunan Kelun Pharmaceutical Co., Ltd.","slug":"hunan-kelun-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"hunankelun.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Etomidate Injectable Emulsion","genericName":"Etomidate Injectable Emulsion","slug":"etomidate-injectable-emulsion","indication":"Induction of general anesthesia","status":"phase_3"}]}],"pipeline":[{"name":"Etomidate Injectable Emulsion","genericName":"Etomidate Injectable Emulsion","slug":"etomidate-injectable-emulsion","phase":"phase_3","mechanism":"Etomidate is a rapid-acting intravenous anesthetic that enhances GABAergic inhibitory neurotransmission in the central nervous system.","indications":["Induction of general anesthesia","Sedation in intensive care settings"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNRlU3TW0tTnBzTnJXMGotTkRzNkFqS2FvclNIZGhldkhUVEJILXFVU1pKOTFjemk5WlBDTEpUQUJxUUtfTlBiREZNcHN6ZncyLXp1eXJqU1lSOW15ek51dWIyTG9mTDlCWGVIMlNCLWVaalAzbTBfVWxORk9ucERjbmVJT2xKY3k4eEowcWl4Q1BSc1NOWFdZbzFsaElZNkpBMEM1Sg?oc=5","date":"2026-01-27","type":"pipeline","source":"BioWorld News","summary":"Asia roundup: Shionogi ups Viiv stake, Fosun spinoff plans, more - BioWorld News","headline":"Asia roundup: Shionogi ups Viiv stake, Fosun spinoff plans, more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQU0xNdU1GbjdNM1hTSzY5QXlVVERxNGFWaEhtSU5YMHBxMURKT3gxT2U2V1hFMHNVa0Q1NE40SUc4SUV2RlNSUXc4Z1RNMW1kNmpWblNWSDBwbFZxb2NnQWhKN3ZKMFFhcUcxeXktUU5rbUdYODd1RFFxMEVBZHlCTHQyOUhHYXBpa1RWcHJxdFBDQnF2ZE9Yd1N6RVpKeVdZcjVKUE9zRkJldW9POUlqOA?oc=5","date":"2025-11-04","type":"pipeline","source":"Contract Pharma","summary":"Merck & Blackstone Enter Research and Development Funding Agreement - Contract Pharma","headline":"Merck & Blackstone Enter Research and Development Funding Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxOVzUyMTV0S3dDRHBxYTl0OHVGVDhDVUZYUVVRMmJteU5LSWd2UVlzd3laN192N05saWxuMVhOa0l2RHhaRWlabHhkUEdtcUctVnY2WnFqRGhubDZ3OHVKOUprbkFjY3FlS0RSWVRubXpuRVgyNHJPNmIwZk5ZLXgwVXJ6Y1FLWkFaeFliQm9sSVJNY3FUN2pRTms3TVp1Q2s2d1BuQXhHVWZmVkdlUE03RzZ5NEhWZUh0NlJ3UEowbmFuZ0ROdVppd0RUdVBCY3o3S3dxTHl4b1hjeTc1WlVIVExadXdMOFNZdnNGTmdCV2YzamZOVnN1N25NZEQ1VFZ5Mk9fMEtvZ1U3VU9mbUJYRXVKYm04QVc4Q2JpY0JPVEx3X1pnX1JZSGRkMnFnVEdfajJSNkczMHVSV1ZTUklpc0hocjYwNnJrOFZuMkFCRTNrSlJ4LVpka1B3OWM?oc=5","date":"2025-09-23","type":"pipeline","source":"PR Newswire","summary":"Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive NSCLC - PR Newswire","headline":"Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Revi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPcEltaEwtVll0Yzl0RkpRWmJBcFkyUWc0OU5NY3NfS2l2VS1hbnYxdUltX1I1LTlGTGpnOVRPVWdPdkJSZFNzU21FRzR1ZUstY05MX3Z3MmRKOUxjOHNKS0xsX1pkZ3dmWDhHbXJJQUYzVGJha3plbEdXRVVZV1FmOGI4a1BBWXZ5WlROek1qeUdMaDBFOFpvVmRIb1RmUG1GMXc?oc=5","date":"2025-08-18","type":"pipeline","source":"PR Newswire","summary":"KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS - PR Newswire","headline":"KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNVjNNalJrTVBBY084TENLSXEwVWJ2V2R1czJzdFZBVjBWN1BuOEpvWEFXU0ZNbnc3Ukk1TkNybDh3Z1BSd3djT1ZUZlNXNW5aZ0NrVFFpTFlvZDlockdNQzQ2RFhNWjQ4eUZlV1J2bC0yMVNXV3Z6RDF2MVdmLVZhSWxyNklxSVdFV0YwZFRVNXVyeDVtb2ZJQkdqRk5xd19zRnNNMDg1NGlNblZraXBJSXlEN21BUXVSYmwyWU9tQQ?oc=5","date":"2025-06-06","type":"pipeline","source":"PR Newswire","summary":"Kelun-Biotech Announces Approximately US$250 Million Placement - PR Newswire","headline":"Kelun-Biotech Announces Approximately US$250 Million Placement","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-28","type":"trial","source":"Business Wire","summary":"Parenteral Nutrition Market Focused Insights 2024-2029 with Exclusive Data on 25+ Vendors - Baxter, B. Braun, Fresenius Kabi, JW Pharmaceutical, Sichuan Kelun, and Grifols Dominate - ResearchAndMarket","headline":"Parenteral Nutrition Market Focused Insights 2024-2029 with Exclusive Data on 25+ Vendors - Baxter, B. Braun, Fresenius ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9iZG1NaEFwUmtFZF8tQnAzdzZlU3hUei1mbDdGS1l2MmVBMDk0bVUwbEdnMlRiemtrUnNvOEhBRjFmQzB1SmF1bDBXTUt3WVhfTERTUHp3?oc=5","date":"2024-05-31","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPMVV5S2E2MGxiMWN1V1N4RnhVdFJmUlUzbHE2b3duQXRmcHJtdU1uX0cyVURtREE3bUMtYXAzY3d3NnZoUnNQeTF2dEx5blcyMjRTc0RkSWhZSHpiNVFhV01tRExiSUJKV1hDRm1tSTNONFNZS2ZYY3VvWWFVb2dVSVJ3ajFDdzhzY19SZ0RDQTByeTdrM3pGWDNRN0RJeVo2ck42aHFMZUQtZUstb2NnMjExLTl4OFdydUx6NllFbEV0Vml1dHRIN2FMRm1udTBnaGFzT0EzSHUwV29pQ1E?oc=5","date":"2023-10-23","type":"pipeline","source":"Reuters","summary":"Merck discontinues some cancer drug development with China's Sichuan Kelun - Reuters","headline":"Merck discontinues some cancer drug development with China's Sichuan Kelun","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNMjdwLWZ1cVptV3F0cGVOcXdjdmprZE00QjFRR2txaDhoTk14V3hlVVdvQVB5SVhKZHlQcWtma3JRUjBMWHhqMXdvQUpkMEZiSnVGaUV0T0hnS2RGQmMtM1ZpSlNVN0JsQ1hiYmZleVFaMUpxUmJjWW9fS0FCa21qSE1Oa29DWWVzeU1sMDc4eEJxX0dtUGdDMUxTNFNpelhEc2t3a0wyb2owSlp4NnJ0VXV2TzdOYk0?oc=5","date":"2023-06-28","type":"pipeline","source":"CEO Insights Asia","summary":"Sichuan Kelun-Biotech Opens Books For $208 Million Hong Kong IPO - CEO Insights Asia","headline":"Sichuan Kelun-Biotech Opens Books For $208 Million Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNExPa3dSeVhTbUFfbjlPYUkxQXFiVzdtQ29ZVWE3MHpjVWZYUkdfZHJYTnNEX09UQzVnNWN5UHFnc3gxcWFoSUlYVnF0M2hweHRka3NyWll3MXBGQVdrc3k5aW1ZTlY1ZHpwTnM5TG1ORThYMFY3YUMzb1U3ZF92SWk2MGZkLS1KclRCUU92QjFFVTJ5WVN4MXRKYzAycnhYMlZEeDdtdWNsMnZiVGFsbEI4MTlYanN6Q0IzZWpRSk5VRHk2QjNqNGlPZHFHQlZiRmk0dWs4RQ?oc=5","date":"2022-09-27","type":"trial","source":"BioSpace","summary":"Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody - BioSpace","headline":"Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5sRFUzVzVEQnlYSUlxcHMtRHc4aW1Fd0pteElLTnNKM2h3dU1ZNmNrRTBvZlJPdXp0ekl4enhRNm5vcUloVnVZR1FVY2t6MTRLYzhBemVBd0ZTMWlPTFFF?oc=5","date":"2021-11-26","type":"pipeline","source":"Nature","summary":"Championing innovations for public and environmental health - Nature","headline":"Championing innovations for public and environmental health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNaVNvMkdUaGVIZFN5QlpBVW5jd0hSZVBBSEtkZGllLXBsQUVZVy1QLWVfUEQ2Q3p4cW0wMTVZNVJGRE45WmlMQV9OSGg2ZmV5Y2x3UGtqNnpmbkhlX2llNzlUUk5rS0NSd2RvM08yRjQzRFVsdlVja2o0TFQtTlAyRE80R2RpcWVuVE8zZ2tRWnlMMEo4X1phelJyMTY?oc=5","date":"2021-05-14","type":"pipeline","source":"openPR.com","summary":"Remdesivir Market To See Huge Growth By 2026 | Gilead Sciences, Hunan Warrant Pharmaceutical, Bright Gene - openPR.com","headline":"Remdesivir Market To See Huge Growth By 2026 | Gilead Sciences, Hunan Warrant Pharmaceutical, Bright Gene","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}